Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up-Reference-Cited by-同舟云学术

Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up

Published:2012 Issue:1 Volume:14 Page:R30
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Houseman Mark,Potter Catherine,Marshall Nicola,Lakey Rachel,Cawston Tim,Griffiths Ian,Young-Min Steven,Isaacs John D

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference16 articles.

1. Progression in early rheumatoid arthritis

2. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

3. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers

4. The Sharp/van der Heijde method out-performed the Larsen/Scott method on the individual patient level in assessing radiographs in early rheumatoid arthritis

5. Cartilage and Bone Biomarkers in Rheumatoid Arthritis: Prediction of 10-year Radiographic Progression

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibroblast-like synoviocytes orchestrate daily rhythmic inflammation in arthritis;Open Biology;2024-07

2. Fibroblast-like synoviocytes orchestrate daily rhythmic inflammation in arthritis;2024-04-03

3. Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer;Experimental & Molecular Medicine;2024-01-04

4. Association of the Clinical and Radiographic Findings at Onset With Future Joint Destruction in Patients With Rheumatoid Arthritis;Cureus;2023-05-24

5. Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis;Science Translational Medicine;2023-02